Cancer

Explore the complexities of Cancer research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against cancer with flcube.com.

anatlas Pharmaceuticals Doses First Patient in Phase II Trial of DAT‑2645 – Novel Targeted Therapy for BRCA‑Mutant, HRD‑Positive Ovarian Cancer
CompanyDrug

Danatlas Pharmaceuticals Doses First Patient in Phase II Trial of DAT‑2645 – Novel Targeted Therapy for BRCA‑Mutant, HRD‑Positive Ovarian Cancer

Danatlas Pharmaceuticals announced that the first subject has been enrolled and dosed in the Phase II clinical study of DAT‑2645, the company's independently developed Class 1 innovative drug, at the…

Danatlas Pharmaceuticals Wins NMPA IND Approval for DAT‑6618 – China's First PPARγ Inhibitor to Enter Clinical Development

Danatlas Pharmaceuticals Wins NMPA IND Approval for DAT‑6618 – China’s First PPARγ Inhibitor to Enter Clinical Development

Ribo Life Science Opens Automated Intelligent Drug Screening Center – A Key Leap in AI‑Powered siRNA Drug Discovery

Ribo Life Science Opens Automated Intelligent Drug Screening Center – A Key Leap in AI‑Powered siRNA Drug Discovery

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval for SHR-1501 Combo in Bladder Cancer
CompanyDrug

Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval for SHR-1501 Combo in Bladder Cancer

Sino Biopharmaceutical's Benmelstobart Meets Primary Endpoint in Phase III NSCLC Study
CompanyDrug

Sino Biopharmaceutical’s Benmelstobart Meets Primary Endpoint in Phase III NSCLC Study

J&J's SC Amivantamab Faces Complete Response Letter from FDA for NSCLC Treatment
CompanyDrug

J&J’s SC Amivantamab Faces Complete Response Letter from FDA for NSCLC Treatment

GSK's Jemperli Receives Positive CHMP Opinion for Endometrial Cancer Indication Extension
CompanyDrug

GSK’s Jemperli Receives Positive CHMP Opinion for Endometrial Cancer Indication Extension

GSK's Jemperli Receives FDA Breakthrough Therapy Designation for Rectal Cancer Treatment
CompanyDrug

GSK’s Jemperli Receives FDA Breakthrough Therapy Designation for Rectal Cancer Treatment

Innovent Biologics Partners with Eli Lilly for Distribution of Jaypirca in China
CompanyDeals

Innovent Biologics Partners with Eli Lilly for Distribution of Jaypirca in China

"Innovent Biologics Initiates Phase I Trial for IBI3009 in Small Cell Lung Cancer and Neuroendocrine Tumors
CompanyDrug

Innovent Biologics Initiates Phase I Trial for IBI3009 in Small Cell Lung Cancer and Neuroendocrine Tumors

Bayer AG Initiates Phase I Study Combining BAY3498264 with Sotorasib for KRAS-Mutated Tumors
CompanyDrug

Bayer AG Initiates Phase I Study Combining BAY3498264 with Sotorasib for KRAS-Mutated Tumors

Show More